Handbook Of Gynecologic Oncolo
Richard R. Barakat, University of Texas M.D. Anderson Cancer Center, Memorial Sloan-Kettering Cancer Center
CRC Press, May 25, 2000 - Medical - 500 pages
A handbook of gynaecologic oncology, offering a comprehensive but concise guide to the therapy of gynaecologic cancer. Edited and written by the faculty of the gynaecologic programmes of MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center, it is designed to be a guide to the diagnosis and treatment of gynaecologic cancer, but it also features chapters on breast and colon cancers. The text should be suitable for fellows and residents in gynaecologic oncology, radiation oncology and medical oncology as well as residents in obstetrics and gynaecologic surgery and medicine.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
abdominal activities of daily acute adjuvant administration agents analgesics antibiotics antiemetics beneﬁt biopsy bleeding bowel brachytherapy breast cancer cancer patients carboplatin carcinoma cells cervical cancer cervix chemotherapy chronic cisplatin classiﬁed clinical colposcopy Dactinomycin daily living Death due debulking decrease deﬁned deﬁnitive diagnosis difﬁcult disabling disease dose drugs due to complication endometrial endometrial cancer evaluation failure FIGO Stage ﬁndings ﬁrst ﬂuid gastrointestinal gestational trophoblastic disease Gynecol Gynecologic Oncology hydatiform moles hypercalcemia hysterectomy increased infection interfering with activities interfering with function invasion irradiation lesions life-threatening lymph nodes malignant metastases methotrexate mg i.v. mg/dl mild mmol/L moderate normal nutritional obstruction Oncol opioid oral ovarian cancer paclitaxel parenteral pelvic peritoneal platelet postoperative preoperative pulmonary q 6 hrs radiation therapy rectal recurrence regimen renal resection serum signiﬁcant speciﬁc studies surgery surgical survival symptomatic symptoms syndrome Table tion tissue transfusion treated trials tumor vaginal variable vulva women